ModuleMD continues to strengthen its position in the field of allergy EHR innovation by leveraging the new generation of AI technology
PR Newswire
2h ago
Ai Focus
At the 2026 Annual Meeting of the American Academy of Allergy, Asthma, and Immunology, ModuleMD showcased its continuously expanding technology ecosystem, which includes WISE Touch AI, automated skin testing, clinical documentation, conversational practice intelligence, and front-end operation tools driven by AI. The company stated that following the recent launch of the WISE Touch web seminar, existing customers have responded positively, indicating an increasing interest in the EHR experience designed for the working methods of specialized clinics.
Helpful
No.Help

After its new WISE Touch AI experience garnered strong interest from customers, ModuleMD showcased a continuously expanding technology ecosystem on ACAAI in 2026, integrating clinical intelligence, automated workflows, and specialty-oriented innovations into allergy clinics.

Phoenix, November 21st / PRNewswire / -- Allergy specialty clinics are facing a set of new requirements. Clinical documentation needs to be completed more quickly. The front desk team has to handle increasingly complex administrative workflows. Patients expect greater transparency, while clinics need technology that truly understands the needs of specialized medical care.

For over 25 years, ModuleMD has been building its technology around these realities. At the 2026 Annual Scientific Meeting of the American Academy of Allergy, Asthma, and Immunology ( ACAAI ) held in Phoenix, Arizona, the company showcased a new generation of AI drive capabilities, aimed at enhancing the way allergy and immunology clinics provide medical services and manage their operations.

At booth 1713, the focus of the discussion was on the continuous development of the ModuleMD EHR platform, especially its latest WISE Touch AI experience. The display also included automated skin testing, clinical documentation, conversational practice intelligence, and front-end operational innovations driven by AI.

This momentum is not limited to the conference venue. Following the recent first preview of the online seminar by WISE Touch, ModuleMD has received a great deal of attention and positive feedback from existing customers, reflecting the growing interest in a EHR experience that is designed around the actual working methods of specialized clinics.

Centered around the allergy specialty, EHR, now takes AI as its core.

Specialized medical technology requires more than just a general-purpose EHR with a few specialized functions attached. Allergology clinics have unique clinical, operational, and revenue cycle requirements, from immunotherapy and skin testing to biologic management and repetitive patient workflows.

The approach of ModuleMD is to build the system from the ground up, centered around these requirements.

Its newly developed WISE Touch AI integrates a redesigned clinical experience with multiple AI functions into a single interconnected platform. ModuleMD does not treat artificial intelligence as a standalone application, but rather embeds it into the daily work of clinicians and clinic teams.

The EHR experience thus formed revolves around three important areas: clinical productivity, administrative automation, and practical intelligent acquisition.

The redesigned clinical experience will make AI auxiliary documents, clinical decision support, and CPT recommendations more closely aligned with the actual diagnostic and treatment settings. WISE Touch AI is designed with the goal of simpler interactions and fewer manual steps, aiming to reduce the administrative workload required for recording and managing patient visits.

The AI clinical documentation provided by JOSH ™ further advances this concept. JOSH is capable of converting natural conversations into structured clinical records, helping clinicians reduce typing time and freeing up more time to focus on patients. This technology supports over 75 languages, integrating conversational documents into the clinical workflow.

ModuleMD Front Desk extends AI into clinic operations through five specialized agents. These agents are responsible for patient reception, scheduling, insurance qualification and cost estimation, authorization, and referrals, with a supervising agent coordinating the process. The goal is to reduce repetitive administrative tasks while maintaining the continuity of key front-office processes.

ModuleMDQ ™ adds another layer of capability through conversational practice. The clinic team no longer needs to switch between multiple interfaces to search for information; instead, they can interact with clinic data using natural language and obtain answers that help advance their work.

These capabilities collectively reflect the broader direction of ModuleMD EHR: clinical workflows, administrative operations, and practical intelligence working together as a system.

Rethink skin testing with AI

The innovations of ModuleMD have also extended to some of the most specific workflows in allergy care.

Skin testing remains a fundamental step in the diagnosis of allergies, but measuring and recording wheal and erythema reactions often involves repetitive manual procedures. The SkinSight™ technology from ModuleMD introduces image-based AI measurement into this process.

Using the existing equipment in the clinic to take images, SkinSight can identify and measure wheals and erythema reactions. The structured results along with the timestamped images are directly uploaded into the patient's medical records.

The integration of measurements, documentation, and clinical records helps to reduce manual data entry, while also allowing clinicians to view and interpret the results. This technology also supports the documentation records of CPT 95004.

SkinSight is developed with full consideration of the workflow in allergy specialist clinics, reflecting an important judgment by ModuleMD regarding AI: technology should solve real clinical problems, rather than merely adding another layer of software.

Customer interest indicates that ModuleMD EHR has entered a new phase.

Only when product innovation truly affects the users does it make sense.

ModuleMD Recently, our WISE Touch held its first webinar preview, giving existing customers the opportunity to learn about the new clinical experience and its interconnected AI capabilities. Feedback indicates that the market has a strong interest in the development direction of this platform, especially the opportunities to more closely integrate clinical documentation, front-office automation, and practical intelligence.

For ModuleMD, this kind of interaction is part of the ongoing relationship it has with the specialized clinics that use its technology every day.

The company continuously develops its EHR around customer needs, the evolving clinical workflows, and the operational realities of independent specialty clinics. This means not only focusing on individual functions but also on how different aspects within the clinic work together in coordination.

The goal is not just to add more features, but to make the technology more useful in every aspect of the interaction between clinicians and their teams with the system.

Not just EHR: An interconnected platform for allergy clinics

The platform of ModuleMD integrates electronic health records, clinic management, patient interaction, revenue cycle management, allergy and immunotherapy, and biologic and infusion management.

This interconnectivity foundation is particularly important for allergy specialist clinics, as clinical care is closely linked to the operation of the clinics. From patient visits and skin tests, to immunotherapy workflows, biologic administration, and revenue cycle management, technology is required to support a complete operational picture.

With over 25 years of specialized medical experience, continuous AI investment, and a platform shaped by customer needs, ModuleMD is consolidating its position in the field of allergy specialist medical technology.

The company's appearance at ACAAI 2026 showcased this direction more closely: the continuously evolving EHR, the AI integrated into real clinic workflows, and technologies designed with the specific needs of allergy care at the center.

As specialized healthcare evolves towards more interconnected and intelligent systems, the focus of ModuleMD remains on enabling technology to better serve the clinics that rely on it.

ModuleMD. A clinic. A platform.

For more information about ModuleMD, please visit www.modulemd.com.

Tip
$0
Like
0
Save
0
Views 52
WalletJYS reminds readers to view blockchain rationally, stay aware of risks, and beware of virtual token issuance and speculation. All content on this site represents market information or related viewpoints only and does not constitute any form of investment advice. If you find sensitive content, please click“Report”,and we will handle it promptly。
Submit
Comment 0
Hot
Latest
No comments yet. Be the first!
Related
Overnight News on November 20: Oil Prices Volatile, S&P 500 Index Drops for Six Consecutive Days Anthropic Debut with Strong Rise Fails to Boost U.S. Stocks, Iran Increases Attacks on Tankers
Overnight market news on November 20th showed that all three major U.S. stock indices fell by more than 2%, with the Dow Jones breaking below 50,000 points, and the S&P 500 index recording a sixth consecutive day of decline; Anthropic made its debut with a 17% increase, but this was not enough to boost overall market sentiment. On a macro level, Trump's trading records from September were exposed, the U.S. Secretary of Energy stated that diesel prices in the U.S. are expected to continue to decline, and Kushner indicated that Trump is open to providing Ukraine with security guarantees similar to NATO's Article 5.
The Block
·2026-11-20 08:31:48
283
Anthropic Listing Causes Fluctuations in U.S. Stocks; AI Has the Jubilation Reached Its Peak and Is It Under New Attention?
Claude Large model developer Anthropic listed on NASDAQ, closing 17.07% higher than its issue price on the first day, with a market value briefly exceeding $2 trillion. However, all three major U.S. stock indices fell more than 2% on that day. Consequently, discussions in the market about whether the performance of AI has peaked, the returns on AI infrastructure investments, and the trends of related tech stocks have intensified.
The Block
·2026-11-20 08:22:14
263
Anthropic IPO Awards Goldman Sachs and Morgan Stanley $113 Million Each in Fees, Exceeding the SpaceX Listing Revenue
On Thursday, IPO brought in at least $550 million in underwriting fees for Wall Street, exceeding the $500 million raised in the SpaceX initial public offering. Goldman Sachs and Morgan Stanley each received $113 million, JPMorgan and Citibank estimated around $55 million each, and Wells Fargo approximately $16.5 million. On the first day, Anthropic rose by 17%, with its market value fully diluting to $1.27 trillion.
Fortune
·2026-11-20 08:10:29
239
Elon Musk claims that SpaceX has developed a plan to eliminate mobile signal dead zones
Elon Musk stated that SpaceX has completed the design of a miniature base station that can be installed on rooftops, with production expected to begin in 2027, aimed at improving mobile phone coverage indoors and eliminating signal dead zones. He also mentioned that the company will launch a constellation of satellites consisting of Direct-to to Cell V2 next year, which will increase bandwidth by 40 times.
TechCrunch
·2026-11-20 07:51:53
248
U.S. Stock Market: S&P 500 Index Drops for Six Consecutive Days Anthropic Debut with Sharp Rise Fails to Boost Market Confidence
The S&P 500 index fell for the sixth consecutive trading day, and the upward trend in tech stocks brought about by the debut of Anthropic could not be sustained, with major stock indices turning lower.
The Block
·2026-11-20 07:32:41
288
View More